Clinical characteristics of children with Omicron variant infection in Chengdu area, China
JIANG Jing, YANG Mei, LI De-Yuan, QIAO Li-Na, ZHANG Hai-Yang
Department of Pediatric Critical Care Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China
Abstract Objective To investigate the clinical characteristics of children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Chengdu of China. Methods A retrospective analysis was conducted for the clinical data of 226 children who were infected with the Omicron variant of SARS-Cov-2 and were isolated and treated in Chengdu Shelter Hospital from August 28 to September 21, 2022. According to the presence or absence of clinical symptoms, they were divided into two groups: asymptomatic group and mild symptomatic group. The two groups were compared in terms of clinical characteristics, diagnosis and treatment, and prognosis. Results Among the 226 children infected with the Omicron variant, 71 (31.4%) were asymptomatic and 155 (68.6%) had mild symptoms. Fever and cough were the most common clinical symptoms, with fever in 95 children (61.3%) and cough in 92 children (59.4%). Of all 226 children, 188 (83.2%) received coronavirus disease 2019 (COVID-19) vaccination. The time to nucleic acid clearance ranged from 6 to 26 days, with a nucleic acid clearance rate of 58.0% (131/226). There were no significant differences among different age groups in sex, early symptoms, clinical typing, nucleic acid re-positive rate, nucleic acid clearance rate, and length of hospital stay (P>0.05). There were no significant differences between the asymptomatic and mild symptomatic groups in age, sex, underlying diseases, COVID-19 vaccination, use of Lianhua Qingwen granules, nucleic acid clearance rate, nucleic acid re-positive rate, and length of hospital stay (P>0.05). Conclusions Children infected with the Omicron variant of SARS-Cov-2 in Chengdu generally have mild clinical symptoms, mainly upper respiratory tract infection, which has little threat to the health of children of different ages, and children tend to have a good overall prognosis.
JIANG Jing,YANG Mei,LI De-Yuan et al. Clinical characteristics of children with Omicron variant infection in Chengdu area, China[J]. CJCP, 2023, 25(8): 849-854.
JIANG Jing,YANG Mei,LI De-Yuan et al. Clinical characteristics of children with Omicron variant infection in Chengdu area, China[J]. CJCP, 2023, 25(8): 849-854.
Hui KPY, Ho JCW, Cheung MC, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo[J]. Nature, 2022, 603(7902): 715-720. PMID: 35104836. DOI: 10.1038/s41586-022-04479-6.
Syed AM, Ciling A, Taha TY, et al. Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles[J]. Proc Natl Acad Sci U S A, 2022, 119(31): e2200592119. PMID: 35858386. PMCID: PMC9351483. DOI: 10.1073/pnas.2200592119.
14 Wang L, Berger NA, Kaelber DC, et al. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron[J]. medRxiv[Preprint]. (2022-01-02) [2022-12-09]. PMID: 35018384. PMCID: PMC8750707. DOI: 10.1101/2021.12.30.21268495.
Acuti Martellucci C, Flacco ME, Soldato G, et al. Effectiveness of COVID-19 vaccines in the general population of an Italian region before and during the Omicron wave[J]. Vaccines (Basel), 2022, 10(5): 662. PMID: 35632418. PMCID: PMC9146679. DOI: 10.3390/vaccines10050662.
Maslo C, Friedland R, Toubkin M, et al. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves[J]. JAMA, 2022, 327(6): 583-584. PMID: 34967859. PMCID: PMC8719272. DOI: 10.1001/jama.2021.24868.
26 Wang L, Berger NA, Kaelber DC, et al. COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after Omicron emerged in the US[J]. medRxiv[Preprint]. (2022-02-22) [2023-01-15]. PMID: 35233579. PMCID: PMC8887070. DOI: 10.1101/2022.02.21.22271300.
